HCV, HIV, HBV AND HDV INFECTIONS IN INTRAVENOUS DRUG-ADDICTS

被引:30
作者
COPPOLA, RC
MANCONI, PE
PIRO, R
DIMARTINO, ML
MASIA, G
机构
[1] Istituto di Igiene e Medicina Preventiva, Universitá degli Studi di Cagliari, Cagliari, I-09124
[2] Cattedra di Immunologia, Universitá degli Studi di Cagliari, Cagliari
关键词
DRUG ADDICTS; HBV; HCV; HDV; HIV;
D O I
10.1007/BF01719350
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Hepatitis viruses and the acquired immunodeficiency viruses often infect intravenous drug addicts (IVDAs). Our study includes 255 IVDAs (26 females and 229 males, aged 20-35 years) from Cagliari. Of 255 subjects examined, 207 (81.1%) were positive for anti-HCV and 84 (32.9%) for anti-HIV. Nineteen (7.4%) subjects were HBsAg carriers, and 12 of these (63%) had an HDV superinfection. Markers of previous HBV infections were tested in 223 cases and 137 (61.4%) were found positive; of these 14 (10.2%) also had HDV infection. Of the 223 drug addicts examined for all infection markers, 18 (8%) were negative to all markers, 46 (20.6%) were positive to only one, 89 (39.9%) were positive to two, 64 (28.7%) to three and 6 (2.6%) were positive to all. Subjects with a single infection were significantly fewer than those with multiple infections. The correlations studied among the various markers did not point out any statistically significant associations. Even so, a previous HBV infection was more common while active HBV/HDV infections were less common among subjects with anti-HCV; HDV infection was more common among HIV-positive subjects. In HBsAg carriers neither HBV-DNA nor HCV-RNA was detected; HCV-RNA was found more frequently in anti-HIV positive subjects than in subjects with the anti-HCV isolate.
引用
收藏
页码:279 / 283
页数:5
相关论文
共 10 条
[1]  
Homann C., Krogsgaard K., Pederson C., Et al., High incidence of hepatitis B infection and evolution in patients with advanced HIV infection, J AIDS, 4, pp. 416-420, (1991)
[2]  
Hoofnagle J.H., Rustgi V.K., Gerin J.L., Et al., Hepatitis B virus infection in the acquired immune deficiency syndrome, Ann Int Med, 101, pp. 795-797, (1984)
[3]  
Caredda F., Antinori S., Coppin P., Et al., The influence of HIV infection on acute and chronic HBsAg positive hepatitis, The Hepatitis Delta Virus, pp. 365-375, (1991)
[4]  
Tor J., Llibre J.M., Carbonell M., Et al., Sexual transmission of HCV and its relation with hepatitis B Virus and HIV, Br Med J, 301, pp. 1130-1133, (1990)
[5]  
Heumer H.P., Prodinger W.M., Larcher C., Et al., Correlation of HCV antibodies with HIV1 seropositivity in intravenous drug addicts, Infection, 18, 2, (1990)
[6]  
Melbye M., Biggar R.J., Wan Tzin P., Krogsgaard K., Ebbesen P., Becker N.G., Sexual transmission of hepatitis C virus: Cohort study (1981–89) among European homosexual men, Br Med J, 301, pp. 210-212, (1990)
[7]  
Masia G., Scarpa B., Uccheddu P., Contu P., Epidemiology of hepatitis B in south Sardinia, L'Igiene Moderna, 2, pp. 221-229, (1990)
[8]  
Mantero G., Zonaro A., Bertolo P., Primi D., DNA enzyme immunoassay (DEIA): A general method for detecting polymerase chain reaction products based on anti-DNA antibody, Clin Chem, 37, pp. 422-429, (1991)
[9]  
Garson J.A., Tedder R.S., Briggs M., Tuke P., Glazebrook J.A., Trute A., Parker D., Barbara J.A.J., Contreras M., Aloysius S., Detection of hepatitis C viral sequences in blood donations by ‘nested’ polymerase chain reaction and prediction of infectivity, Lancet, 335, pp. 1419-1422, (1990)
[10]  
Imberti L., Cariani E., Bettinardi A., Zonaro A., Albertini A., Primi D., An immunoassay for specific amplified HCV sequences, J Virol Meth, 34, pp. 233-243, (1991)